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MotivationIntroduction: It is not known how well motivation to stop smoking predicts abstinence in a clinical sample rela-
tive to the most widely used measure of cigarette dependence.
Methods: A secondary analysis was conducted from a trial with 864 smokers making quit attempt. Fagerström
Test of Cigarette Dependence (FTCD), Heaviness of Smoking Index (HSI), and motivation to stop smoking (com-
posite of determination to quit and importance of quitting) weremeasured at baseline. Continuous smoking ab-
stinence, validated by expired-air carbonmonoxide, was assessed at 4weeks, 6months and 12months post-quit
date. FTCD, HSI, non-HSI items in FTCD, and motivation were assessed as predictors of abstinence.
Results: In multiple-logistic regressions, controlling for age, gender and medication use, lower scores for FTCD,
HSI and non-HSI all significantly predicted abstinence at all follow-ups, while motivation did not predict absti-
nence at any time. Likelihood ratio tests showed that the FTCD contributed most to the model at 4 weeks and
6months; at 12months FTCD and non-HSI equally contributedmost to themodel. At 4weeks and 6months, pre-
dictions were improved by combining HSI and non-HSI components, compared with using these components
alone.
Conclusions: Cigarette dependence, measured by the FTCD, or by its HSI or non-HSI components, predicts both
short-term and medium-term outcomes of attempts to stop smoking in treatment-seeking smokers involved
in a clinical trial, whereas strength of motivation to stop predicts neither. Both the HSI and non-HSI components
may be considered as briefer alternatives to the full FTCD.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Data from population samples show that motivation to stop
smoking predicts incidence of quit attempts but does not generally pre-
dict the success of those attempts; whereas cigarette dependence does
not consistently predict quit attempts but does predict relapse to
smoking following those attempts (Vangeli, Stapleton, Smit, Borland,
& West, 2011). This issue is central to our understanding of factorsrch Institute, Hunter Wing, St.
SW17 ORE, UK.
. This is an open access article underthat promote or inhibit different parts of the quitting process and has
implications for targeting interventions that promote and aid quit at-
tempts (West, 2009).
Clinical samples (i.e., smokers who proactively seek stop-smoking
treatment in a stop smoking clinic) are also important to study because,
compared with population studies, they generally provide an opportu-
nity for measuring motivation and dependence immediately prior to
the quit attempt, include greater rigour of measurement of outcome,
and permit better control of the conditions underwhich quitting occurs.
A range of factors might contribute to differences between studies, in-
cluding themeasures used, the samples, and the duration of abstinence.
As regards dependence, studies from clinical samples, with smokersthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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compared with population studies, with dependence predicting quit
success in some studies (Breslau & Johnson, 2000; Courvoisier & Etter,
2010; Ferguson et al., 2003; Japuntich, Leventhal, Piper, et al., 2011;
Kozlowski, Porter, Orleans, Pope, & Heatherton, 1994) and other studies
failing to observe this effect (Etter, 2005; Frikart, Etienne, Cornuz, &
Zellweger, 2003; Piper, Piasecki, Federman, et al., 2004; Piper,
McCarthy, & Baker, 2006). Dependence could be a more consistent pre-
dictor of abstinence in population studies, compared with clinical stud-
ies, because population samples tend to have a wider range of
dependence.
For motivation, clinical studies have recruited a mixed sample of
smokers wanting to quit and those not interested in quitting and have
shown that motivation predicts success (Cox, Wick, Nazir, et al., 2011;
Sciamanna, Hoch, Duke, Fogle, & Ford, 2000); however, in these studies,
the results are confounded by combining, in the analysis, smokers who
have and have notmade a quit attempt.We could identify only two clin-
ical studies in which the entire sample were treatment-seeking
smokers, attempting to quit smoking, and motivation (assessed as de-
termination to quit) predicted the success of quit attempts up to 12
months of abstinence in one study (Bauld, Ferguson, McEwen, &
Hiscock, 2012) but not in the other study (Ferguson, Bauld,
Chesterman, & Judge, 2005). However, these studies recruited smokers
from routine smoking cessation clinics in the English National Health
Service and it is not clear whether all the participants actually tried to
quit (i.e., made it to their quit date), and that could influence the
findings.
The present study aimed to add to the evidence base on associations
between motivation to quit, cigarette dependence and success of quit
attempts by employing a large clinical sample,making a definite quit at-
tempt, and with data on both short- and medium-term follow-up with
half the sample receiving no medication in support of the attempt. It
provided a robust test of the relative predictive power of these mea-
sures through applying a strict criterion for abstinence, involving no
self-reported smoking from the quit date onwards, with biochemical
verification at 1, 2, 3 and 4 weeks and at 6 months and 12 months
after the target quit date. Use of a strict abstinence criterion
(e.g., lapse-free abstinence from the quit date) is important as weaker
outcome measures (e.g., point prevalence — typically defined as not
smoking on the day of follow-up or for a specified number of days be-
fore a follow-up) are contaminated by some ‘successes’ being only tran-
sient arising after failure of the initial quit attempt (West, Hajek, Stead,
& Stapleton, 2005).
The most commonly used self-report measure of cigarette depen-
dence is the Fagerström Test for Cigarette Dependence (FTCD, previ-
ously known as the Fagerström Test for Nicotine Dependence)
(Heatherton, Kozlowski, Frecker, & Fagerstrom, 1991; Fagerstrom,
2012) which has been found to predict success at stopping smoking
in some studies (Breslau & Johnson, 2000; Courvoisier & Etter, 2010;
Ferguson et al., 2003; Japuntich et al., 2011; Kozlowski et al., 1994), al-
though other studies have found no relationship with quitting success
(Etter, 2005; Frikart et al., 2003; Piper et al., 2004). Measures based on
self-rated dependence or Diagnostic and Statistical Manual of Mental
Disorders (DSM) criteria typically fail to predict quitting outcomes
(Piper et al., 2006; DiFranza, Ursprung, Lauzon, et al., 2010; Piper,
McCarthy, Bolt, et al., 2008). A scale composed of two items from the
FTCD, time to first cigarette of the day and number of cigarettes usual-
ly smoked per day (i.e., Heaviness of Smoking Index (HSI)),
(Heatherton, Kozlowski, Frecker, Rickert, & Robinson, 1989) has been
shown to predict failure of quit attempts at least as well as the full
scale, whether in population studies (Courvoisier & Etter, 2010;
Fidler, Shahab, & West, 2011) or in clinical studies with treatment
seeking smokers who are motivated to quit (Kozlowski et al., 1994;
Baker, Piper, McCarthy, et al., 2007; Burling & Burling, 2003;
Fagerstrom, Russ, Yu, Yunis, & Foulds, 2012). Overall, as these studies
found no evidence of superiority of the FTCD over the HSI forpredicting abstinence, they have encouraged use of the HSI as a
more economical substitute for the FTCD. However, these studies
used a point-prevalence measure of abstinence which, as argued
above, has limitations. It would be useful to collect more data from
clinical samples to determine whether the non-HSI parts of the FTCD
predict outcome over and above the HSI.
As regards use of multiple follow-up points, it might be expected
that cigarette dependence would be more successful in predicting
short-term than medium or long-term relapse to smoking. This is be-
cause relapse after the initial period of cigarette withdrawal symptoms
might bemore of a randomevent, arising froma range of environmental
and social triggers. This is also consistent with the proposal that the
FTCD is predominantly a measure of physical dependence (DiFranza
et al., 2013; Moolchan, Radzius, Epstein, et al., 2002).
Thus, this study addressed the following questions: (i) How well do
motivation to stop smoking and cigarette dependence measured just
prior to a quit attempt in a clinical sample of treatment-seeking
smokers predict short-term (i.e., at 4 weeks) and medium-term
(i.e., at 6 or 12 months) abstinence? (ii) How do the HSI and non-
HSI parts of the FTCD compare as predictors of short- and medium-
term abstinence?
2. Methods
2.1. Design and interventions
This study involved secondary data analysis from a double-blind
placebo-controlled trial of glucose tablets for smoking cessation
(West et al., 2010) Information on demographic characteristics and
smoking patterns was gathered by means of a postal questionnaire
completed at one to four weeks before the quit date. All participants
attended the clinic 1 week prior to their target quit date, on their
quit date, then weekly up to 4 weeks after their quit date, totalling
six sessions over 5 weeks. At each session, they received 60 min of
group-based behavioural support (Stead & Lancaster, 2012). Partici-
pants were randomised to receive either glucose tablets or sorbitol
tablets (placebo), supplied up to 6 weeks after the quit date. In addi-
tion, within the both groups, participants were randomised to receive
either stop smoking medication (nicotine replacement therapy (NRT)
and/or bupropion) or no medication, which were prescribed up to
8 weeks post-quit. Participants were followed up 1, 2, 3, 4, 26, and
52 weeks post-quit date.
2.2. Participants
Smokers wanting help with stopping smoking were recruited
through general practitioner referral, word of mouth, and advertising.
They were excluded if under 18, diabetic, currently smoking b ten cig-
arettes a day, unable to read and write English, or if they reported a
current psychiatric condition. Written informed consent was obtained.
Nine-hundred-twenty-eight participants were recruited over a
19 month period between November 2006 and May 2008. The eligibil-
ity criteria were clearly outlined in the invitation letter and it was not
necessary to exclude anyone who expressed interest in taking part. As
the study was investigating the prediction of success of quit attempts,
only the 891 (96%) who made a quit attempt were included. Twenty-
seven participants with missing FTCD scores were excluded from the
analysis. The characteristics of those included were very similar to
the excluded 27. Eight-hundred-sixty-four (93.1%) participants were
included in the analysis.
2.3. Measures
Prior to the quit attempt, demographics, motivation to quit and cig-
arette dependencewere assessed. Demographics, including age, gender
and occupation were assessed by the postal questionnaire.
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Determination to quit was measured twice: by the postal question-
naire prior to the quit date and at the quit date session: “How deter-
mined are you to give up smoking at this attempt?” (not all that
determined = 1, quite determined = 2, very determined = 3, greatly
determined=4, extremely determined=5) (West &Willis, 1998). Im-
portance of quitting was measured once by postal questionnaire: “How
important is it to you to give up smoking altogether at this attempt?”
(not all that important = 1, quite important = 2, very important = 3,
desperately important = 4) (adapted from Miller & Rollnick, 1991)
Following the analysis it was decided to combine the measures of
motivation to produce a single composite score (see first paragraph
of Results).
2.3.2. Cigarette dependence
Cigarette dependence was assessed by the postal questionnaire,
prior to the quit date, using the FTCD (scored 0–10) (Heatherton et al.,
1991; Fagerstrom, 2012) which consists of six items: daily cigarette
consumption scored 10 or less = 0, 11–20 = 1, 21–30 = 2, 31 or
more = 3; time to first cigarette of the day (31+ min = 0, 6–
30 min = 2, 0–5 min = 3); difficulty not smoking in no-smoking
areas (No = 0, Yes = 1); which cigarette would most hate to give up
scored (‘first of the morning’= 1, others = 0); smoke more frequently
in first hours after waking (No = 0, Yes = 1); smoke when ill in bed
(No= 0, Yes = 1). Higher scores FTCD scores indicate greater cigarette
dependence. The first two FTCD items make up the Heaviness of
Smoking Index (HSI, scored 0 to 6) (Heatherton et al., 1989).
Use of stop smoking medications (NRT or bupropion) was assessed.
Smoking abstinence was defined as continuous, self-reported lapse free
abstinence from the target quit date to 4 weeks, 6 months and 12
months confirmed at each follow-up (i.e., at weeks 1, 2, 3, 4, 26 and
52weeks post-quit date) by expired-air CO b 10 ppm. As is convention-
al, participants lost to follow-up were considered to have relapsed
(West et al., 2005).
2.4. Analysis
Descriptive statistics were produced for the participant and treat-
ment characteristics, both for the whole sample and according tomedi-
an splits on FTCD and motivation to quit. Chi-squared and t-tests were
used to compare the sample characteristics according to these splits.
The reliability (internal consistency) of the dependence and motivation
measures were assessed using Cronbach's alpha. Using logistic regres-
sion, bivariate associations were examined between dependence/moti-
vation measures and smoking abstinence (abstinent = 1, non-
abstinent = 0) at 4 weeks, 6 months and 12 months.
The primary analyses involved multiple-logistic regressions with
smoking abstinence at 4 weeks, 6 months and 12months as dependent
measures. It was decided a priori to first fit a basic model with five co-
variates as independent variables: age, gender (female = 1, male =
0), occupation (1 = professional managerial, 0 = other occupation, as
an indicator of socio-economic status), medication use (NRT or
bupropion = 1, no medication = 0), and whether receiving glucose
(code 1) or placebo (code 0) tablets as they are potentially important
prognostic factors for smoking cessation. Those receiving glucose versus
placebo tablets did not differ on rates of smoking abstinence at any
time; therefore, assignment to glucose or placebo was not ultimately
controlled for.
In thenextmodel FTCD scorewas added to the basicmodel. The like-
lihood ratio test was used to assess whether the FTCD improved the
basicmodel (i.e., significantly increased the prediction of smoking absti-
nence). The latter analysis was repeated, without the FTCD, addingmo-
tivation, HSI, and non-HSI separately to the basicmodel.We then tested
whether adding motivation improves the models for FTCD, HSI or non-
HSI. Finally, we assessed whether adding non-HSI improves the model
for HSI, and vice versa. In all the regression models, we tested theinteraction terms for age, gender and use ofmedicationwith the predic-
tors, and the interaction term for motivation score with FTCD, HSI,
and non-HSI using likelihood ratio tests. For the significant predic-
tors, we used the likelihood ratio test to assess whether covariates
moderate the results significantly. To assess the effect of the as-
sumption that those lost to follow-up had relapsed, all the analyses
were repeated when only including those who were followed-up
and confirmed as abstinent. The analysis was conducted using
SPSS version 21 and Stata version 12.
3. Results
The sample characteristics are presented in Table 1. The numbers
lost to follow-up and presumed to be smoking were: four participants
at fourweeks, 66 at sixmonths, and 17 at 12months.When only includ-
ing thosewhowere followed-up all the following resultswere very sim-
ilar. The Cronbach's alpha for the dependence scores were: FTCD 0.61,
HSI 0.54, non-HSI 0.46. The two measures of ‘determination to quit’
were significantly correlated (Pearson's r = 0.493, p b 0.001) and we
combined them in order to increase the reliability of the measure and
to give it every possible chance to predict outcome. Very similar results
were obtainedwhen using either of the determination ratings individu-
ally. As the ‘importance of quitting’ item was significantly correlated
with the combined determination item (r = 0.513, p b 0.001) and the
Cronbach's alpha for the three items (i.e., two determination items
and importance item) was acceptable (0.71), in order to arrive at the
most accurate measure available to us, we combined the items in a sin-
glemeasure of motivation to quit (range of scores: 3 to 14). All the find-
ings were very similar whether we used the combined motivation
measures or if we used determination and importance separately. The
mean (SD, actual range of scores) dependence and motivation scores
were: FTCD 5.8 (2.3, 0–10), HSI 3.7 (1.5, 0–6), non-HSI 2.1 (1.2, 0–4),
motivation 12.0 (2.0, 6–14).
Table 2. shows the unadjusted (i.e., bivariate) and adjusted odds ra-
tios for the dependence and motivation scores at the three follow-up
points. When adding occupation as a covariate there was minimal
change in any of the results for the regressions. As there were 40 cases
missing for occupation, in order to preserve the sample size, occupation
was excluded from the findings presented in Table 2. Table 2. also pre-
sents the findings for the likelihood ratio tests, which assessed whether
the basic model is improved by adding any of the dependence variables
or the motivation variable. At four weeks, in the adjusted regressions,
lower scores for FTCD, HSI and non-HSI all significantly predicted absti-
nence at p b 0.001. The likelihood ratio test indicated that the basic
model was improved most by adding FTCD (χ2 = 30.27), followed by
HSI then non-HSI (χ2 = 24.03, 19.29, respectively); however, all three
dependence variables were highly significant with the likelihood ratio
test (all p b 0.001). At 4 weeks, having already added HSI to the basic
model, adding non-HSI significantly further improved the model
(χ2 = 6.28, p = 0.012). Similarly, adding HSI to the adjusted model
for non-HSI significantly improved the model at four weeks (χ2 =
11.02, p b 0.001).
At six months, the adjusted regressions showed that, as for 4 weeks,
each of the dependence variables significantly predicted abstinence at
p b 0.001 (see Table 2.). According to the likelihood ratio test, FTCD
once again contributed most to the basic model (χ2 = 18.98), followed
by non-HSI (χ2= 15.13) and HSI (χ2= 12.72), with all three reaching a
significance of p b 0.001. Having added HSI to the basic model, adding
non-HSI further improved the model (χ2 = 6.60, p = 0.010). Likewise,
adding HSI to the adjusted model for non-HSI improved the model at 6
months (χ2 = 4.19, p = 0.041), though to a lesser extent than at 4
weeks.
At 12 months, in the adjusted model, abstinence was significantly
predicted by each of the dependence variables (see Table 2). The basic
model was improved to a greater extent by adding FTCD and non-HSI
(χ2 = 12.19, 13.23, respectively), than when adding HSI (χ2 = 5.96).
Table 1
Participant characteristics according to median split for scores for FTCD and motivation (N = 864).a
Variableb Total sample,
N = 864
FTCD score ≤ 5
(n = 363)
FTCD score ≥ 6
(n = 501)
Motivation score ≤ 12
(n = 458)
Motivation score ≥ 13
(n = 406)
No. (%) No. (%) No. (%) No. (%) No. (%)
Female 539 (62.4) 225 (62.0) 314 (62.7) 268 (58.5)⁎ 271 (66.7)
Professional/managerial occupation (N = 824c) 239 (27.7) 121d (34.6)⁎⁎ 118e (24.9) 145f (33.1)⁎⁎ 94g (24.4)
Any use of smoking cessation medication 419 (48.5) 158 (43.5)⁎ 261 (52.1) 197 (43.0)⁎ 222 (54.7)
Abstinent from smoking up to 4 weeks 303 (35.1) 157 (43.3)⁎⁎⁎ 146 (29.1) 151 (33.0) 152 (37.4)
Abstinent from smoking up to 6 months 122 (14.1) 71 (19.6)⁎⁎⁎ 51 (10.2) 61 (13.3) 61 (15.0)
Abstinent from smoking up to 12 months 68 (7.9) 44 (12.1)⁎⁎⁎ 24 (4.8) 34 (7.4) 34 (8.4)
Mean (SD) No. (%) No. (%) No. (%) No. (%)
Age 44.2 (12.4) 42.3 (12.5)⁎⁎⁎ 45.6 (12.2) 43.9 (12.7) 44.6 (12.2)
FTCD= Fagerström Test of Cigarette Dependence.
For each sample characteristic, significance (in bold) for difference between FTCD ormotivation groups using chi-squared or t-tests: ⁎p b 0.05, ⁎⁎p b 0.01⁎⁎⁎p b 0.001. Denominators: d350,
e474, f438, g386.
a Sum of ratings of determination to quit and importance of quitting.
b Ethnic group not recorded.
c Missing data for 40 participants not declaring an occupation.
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(χ2 = 8.13, p = 0.004). While, adding HSI to the adjusted model for
non-HSI did not improve this model (χ2 = 0.86, p = 0.353).
Motivation did not significantly predict abstinence, or improve the
basicmodel, at any timepoint.Moreover, addingmotivation did not sig-
nificantly improve the adjusted model for any of the dependence vari-
ables at any time point (range for likelihood ratio tests: χ2 = 0.01 to
1.40). None of the interactions reached statistical significance. Likeli-
hood ratio tests showed that the covariates significantly moderated
the findings for: FTCD, HSI and non-HSI predicting abstinence at
4 weeks (χ2 = 22.89, p b 0.001, χ2 = 23.13, p b 0.001, χ2 = 18.19, p b
0.001, respectively) and for FTCD and HSI predicting abstinence at 6
months. The covariates did not significantly moderate the findings for
non-HSI at 6 months or for any of the dependence variables at 12
months. There was no evidence of substantial multicollinearity among
any of the independent variables in the multiple regressions.Table 2
Odds ratios and likelihood ratios for measures of tobacco dependence and motivation predictin
Unadjusted bivariate associations (independent variables, per point increase)
FTCD
HSI
Non-HSI items from FTCD
Motivation to quit
Adjusteda multiple regressions Time of smoking abstinence assessment (depende
4 weeks 6
OR (95% CIs) LRb χ2 O
FTCD 0.84 (0.78–0.89) 30.27 0
p b 0.001⁎⁎⁎ p b 0.001⁎⁎⁎ p
HSI 0.78 (0.71–0.86) 24.03 0
p b 0.001⁎⁎⁎ p b 0.001⁎⁎⁎ p
Non-HSI items from FTCD 0.77 (0.68–0.87) 19.29 0
p b 0.001⁎⁎⁎ p b 0.001⁎⁎⁎ p
Motivation to quit 1.02 (0.95–1.09) 0.18 0
p = 0.673 p = 0.672 p
OR (95% CIs) = odds ratio (95% confidence intervals).
Results shown in bold are significant at: ⁎⁎⁎p b 0.001, ⁎⁎p b 0.01, ⁎p b 0.05.
FTCD= Fagerström Test of Cigarette Dependence, HSI = Heaviness of Smoking Index, LR χ2 =
a All regressions adjusted for the covariates of age, gender and use of medication.
b Likelihood ratio test to assess the extent towhich adding each variable (i.e., FTCD, HSI, non-
prediction of smoking abstinence.4. Discussion
Cigarette dependence, whethermeasured by the FTCD, or by the HSI
or non-HSI parts of the FTCD, significantly predicted both short-term
and medium-term smoking abstinence. Motivation to stop did not pre-
dict abstinence at any time. For 4 week and six-month abstinence the
FTCD contributed most to the model; while at 12 months the non-HSI
and FTCD contributed most. Combining the two FTCD components im-
proved the contribution at 4 weeks and six months but not at 12
months. The internal consistency of the FTCD and HSI and non-HSI
parts of the FTCD was poor and slightly lower than that of the motiva-
tion scale.
The findings provide possibly the most robust evaluation of the rel-
ative power ofmeasures of cigarette dependence andmotivation to stop
smoking in predicting the outcome of smoking cessation attempts. Use
of continuous lapse-free validated abstinence and multiple follow-upg smoking abstinence (N = 864).
Time of smoking abstinence assessment (dependent variable)
4 weeks 6 months 12 months
OR (95% CIs) OR (95% CIs) OR (95% CIs)
0.86 (0.81–0.92) 0.85 (0.78–0.92) 0.83 (0.75–0.93)
p b 0.001⁎⁎⁎ p b 0.001⁎⁎⁎ p = 0.001⁎⁎
0.82 (0.75–0.90) 0.82 (0.73–0.93) 0.83 (0.71–0.97)
p b 0.001⁎⁎⁎ p = 0.002⁎⁎ p = 0.023⁎
0.79 (0.70–0.88) 0.74 (0.63–0.86) 0.68 (0.55–0.84)
p b 0.001⁎⁎⁎ p b 0.001⁎⁎⁎ p b 0.001⁎⁎
1.03 (0.96–1.11) 0.98 (0.89–1.08) 0.94 (0.83–1.06)
p = 0.391 p = 0.687 p = 0.300
nt variable)
months 12 months
R (95% CIs) LRb χ2 OR (95% CIs) LRb χ2
.83 (0.76–0.90) 18.98 0.83 (0.74–0.92) 12.19
b 0.001⁎⁎⁎ p b 0.001⁎⁎⁎ p b 0.001⁎⁎⁎ p b 0.001⁎⁎⁎
.79 (0.69–0.90) 12.72 0.81 (0.69–0.96) 5.96
b 0.001⁎⁎⁎ p b 0.001⁎⁎⁎ p = 0.013⁎ p = 0.015⁎
.73 (0.62–0.86) 15.13 0.68 (0.55–0.84) 13.23
b 0.001⁎⁎⁎ p b 0.001⁎⁎⁎ p b 0.001⁎⁎ p b 0.001⁎⁎⁎
.98 (0.89–1.08) 0.22 0.95 (0.84–1.07) 0.70
= 0.636 p = 0.638 p = 0.398 p = 0.403
chi-squared value for likelihood ratio test.
HSI, motivation) separately to the basic model (i.e., model with covariates only) affects the
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good reliability and similar variation as the dependence measures,
strengthen the conclusion that dependence but not baselinemotivation
to quit, within the ranges seen in a typical sample seeking treatment in a
stop smoking clinic, is important in determining the success of quit at-
tempts. This informs us about where interventions need to focus in
helping quit attempts among thosewho seek treatment (e.g., in helping
people avoid and manage urges to smoke, rather than in assessing and
boosting motivation towards quitting among smokers attending prior
to attempting to quit). However, this research does not address motiva-
tion over the course of the quit attempt. It may be that whenmotivation
drops, during a quit attempt, that change predicts relapse. It must also
be considered that motivation is likely to be more unstable over time
than dependence. This would tend to militate against showing an asso-
ciation with cessation outcomes. It remains possible, or even likely, that
motivation measured continuously after the quit attempt would pro-
vide insights into the lapse and relapse processes. However, it may
also be noted that motivation has enough stability for it to predict quit
attempts over a 6 month period (Kotz, Brown, & West, 2013). Alterna-
tively, it may be that motivation is key for initiating a quit attempt,
but dependence is important as regards abstinence. Also, smokers seek-
ing treatment in other contexts, such as when seeing a physician, nurse
or midwife, may have lower motivation to quit, when compared with
the current sample, and increasing motivation among these individuals
may be beneficial. Thus, the findings are not generalizable beyond those
smokers who proactively seek stop-smoking treatment in a stop
smoking clinic, andwhohave also volunteered to participate in a clinical
trial.
The finding that the non-HSI part of the FTCD added predictive
power over and above the HSI at all three follow-ups, and that it was
the non-HSI parts, rather than HSI, that contributed most at 6 and 12
months, suggests that the non-HSI may be important. The full scale
has only six items and the additional resources required to use it over
and above the HSI are small; therefore, it would seem prudent to use
the full scale, at least up to 6 months. It is not clear why the non-HSI
items, relative to the HSI items, are more important as predictors of
quit success as the duration of abstinence increases. As non-HSI per-
formed similarly to the FTCD as 12 months, the non-HSI may provide
a briefer alternative to FTCD at this time; however, this is the first
study to observe such results for the non-HSI and replication is required.
The study had limitations. Fewer low dependency smokers were in-
cluded than might be found in the general smoking population (mean
FTCD score in this study: 5.8; mean FTCD score for the general smoking
population: 3–4) (Fagerstrom& Furberg, 2008). Dependence levelsmay
also be slightly higher than in treatment seeking smokers in general,
where those smoking less than 10 cigarettes would not be excluded, al-
though as a rule smokers seeking treatment are highly dependent as
less dependent smokers are able to quit unaided. Consequently, the var-
iation in FTCD scores in this analysis may be restricted and the findings
may be slightly different if more low dependency smokers were includ-
ed. Secondly, as with most clinical data, these findings are based on
smokerswho are attendingmultiple clinic visits and theymay not read-
ily extrapolate to smokers attending fewer visits.Moreover, participants
were willing to enrol for a prolonged clinical trial and thus were highly
motivated at the outset; however, they were also motivated to quit;
therefore further fine distinctions in level of motivation, related to join-
ing a trial, would be unlikely to have a major impact. Smoking absti-
nence was validated by the standard measure of expired CO; however,
the rigour of the validation could have been improved by also assessing
cotinine levels (Etzel, 1990).
There are potential limitations concerning the validity of themotiva-
tionmeasure. Assessing the validity of amotivationmeasure in this con-
text is subject to conceptual issues with regard to finding a criterion
against which to assess it. Given the hypothesis that baselinemotivation
is not likely to be a good predictor of sustained abstinence, we cannot
easily use abstinence as a criterion of pre-quit motivation. We are notaware of any other readily available behavioural criteria in a study of
this kind. Another way of comparing the psychometric properties of
the measures is their internal reliability. In that regard, the motivation
measure and the FTCD performed similarly and in fact the FTCD
has been criticised for weak psychometric properties (Heatherton
et al., 1991; Payne, Smith, McCracken, McSherry, & Antony, 1994;
Pomerleau, Carton, Lutzke, Flessland, & Pomerleau, 1994; Sledjeski
et al., 2007). Nevertheless, it remains possible that conclusions relating
to the differential predictive ability of dependence andmotivationmea-
sures may be due to differences in the validity of the two measures.
Moreover, motivation measures such as those related to determination
and importance are reflective of the initial ‘desire’ to quit and may not
predict quit success because they do not tap into the ability to work
through the challenges of quitting, particularly in terms of the mental
energy required for the inhibitory-control of smoking behaviour
(West, 2009). Measures are needed which assess more behavioural as-
pects of motivation, such as self-control. This is a difficult proposition as
motivation is an internal construct and may not be easily amenable to
behavioural assessment.
It is also noteworthy that the meanmotivation score of 12 was high
(maximum score = 14), with a standard deviation of just 2, raising the
potential for a ceiling effect. High motivation can be expected in
smokers who enlist for multisession treatment and who volunteer for
a clinical trial, and the heterogeneity in motivation to quit may have
limited the potential to predict abstinence. However, it could also be ar-
gued that the potential ‘ceiling effect’ reinforces rather than weakens
the finding. It suggests that people who pro-actively seek help in stop-
ping smoking are, not surprisingly, well-motivated to quit and that
the reason they cannot quit unaided is that they are dependent rather
than that they do not want to quit. Thus, it is useful to know that once
people have got to the point of making a quit attempt in a stop smoking
clinic, a measure of motivation is not predictive of success while a mea-
sure of dependence is. The samemotivation measure may predict stop-
smoking outcome in a general population of smokers, where levels of
motivation are likely to vary more widely. Similar limited variation,
however, was also present inmeasures of dependence. As with anymo-
tivation measure of this type, there is also the risk of social desirability
leading to reports of inflated motivation scores, although this is likely
to have been lessened by the questionnaire being postal rather than
being administered face-to-face.
In conclusion, in highly dependent treatment-seeking smokersmak-
ing a quit attempt in a clinical trial, cigarette dependence is a significant
predictor of both short-term andmedium-term abstinence, while moti-
vation, assessed through pre-quit ratings of ‘determination to quit’ and
‘importance of quitting’, is not. Besides the full FTCD, the HSI and non-
HSI components of the FTCD are also both strong predictors of absti-
nence. Predictive ability is generally improved by combining the HSI
and non-HSI, compared with using these components alone, suggesting
that the FTCD is the best predictor.
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